ANCA-MARIA BEJENARU: Open Payments
NPI 1861999807 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,462 in 59 payments from 15 companies in 2025. Trend: 2023 $1,650 · 2024 $2,036 · 2025 $1,462
Food & beverage: $1,462
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $254 |
| Janssen Pharmaceuticals, Inc | 3 | $148 |
| E.R. Squibb & Sons, L.L.C. | 5 | $131 |
| Lundbeck LLC | 4 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $108 |
| Corium, LLC | 5 | $102 |
| Alkermes, Inc. | 4 | $96 |
| Almatica Pharma LLC | 4 | $83 |
| Bausch Health US, LLC | 3 | $79 |
| Janssen Scientific Affairs, LLC | 2 | $73 |
Products named: VRAYLAR, SPRAVATO, REXULTI, COBENFY, CAPLYTA, Azstarys, LOREEV XR, APLENZIN.
Industry payments across OR — which companies pay providers there.
